Assunta Fabozzo, Valentina Lombardi, Giorgia Cibin, Emma Bergonzoni, Giulia Lorenzoni, Dario Gregori, Chiara Tessari, Daniela Bacich, Augusto D'Onofrio, Giuseppe Toscano, Antonio Gambino, Vincenzo Tarzia, Nicola Pradegan, Gino Gerosa
{"title":"心脏移植受者营养不良通用筛查工具的预后评估:一项试点研究和单中心经验。","authors":"Assunta Fabozzo, Valentina Lombardi, Giorgia Cibin, Emma Bergonzoni, Giulia Lorenzoni, Dario Gregori, Chiara Tessari, Daniela Bacich, Augusto D'Onofrio, Giuseppe Toscano, Antonio Gambino, Vincenzo Tarzia, Nicola Pradegan, Gino Gerosa","doi":"10.3390/jpm14121140","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction and aims</b>: Malnutrition is associated with increased morbidity and mortality in patients who undergo cardiac surgery. Nevertheless, objective assessment of malnourished patients undergoing heart transplantation (HT) is limited. We aimed to analyze the relationship between the malnutrition status and the early and late clinical outcomes of patients undergoing HT using a novel semi-quantitative tool. <b>Methods</b>: All patients aged ≥18 years who underwent HT between January 2015 and July 2020 in a single center were retrospectively evaluated and included in the study. The semi-quantitative Malnutrition Universal Screening Tool (MUST) score (already validated in heart failure) was calculated for each patient at the time of transplantation to assess their nutritional status. A propensity score weighting approach was performed to evaluate the association between the increase in MUST score and the risk of early complications and in-hospital mortality. A Cox regression analysis was performed to assess follow-up mortality. <b>Results</b>: A total of 168 HT patients (median age 58.4 years, IQR 49.5-65.2, men <i>n</i> = 128, 76%) were included within the study period. Their median preoperative BMI was 24.0 kg/m<sup>2</sup> (IQR 21.2-27.9). Preoperative MUST scores of 0, 1, and ≥2 were found in 92 (55%), 24 (14%), and 52 (31%) patients, respectively. The median preoperative eGFR was 64.3 mL/min (IQR 49.0-83.2). An increase in MUST score (from 0 to 2) was not significantly related to major postoperative complications or in-hospital mortality. An analogous increase in MUST score was associated with increased follow-up mortality risk (hazard ratio 1.28, 95% CI 1.04-1.83, <i>p</i> = 0.024). <b>Conclusions</b>: Malnutrition assessed with the MUST score seems not to be associated with increased in-hospital mortality or major postoperative complications in patients who undergo HT, but according to our preliminary data it is related to patients' long-term mortality.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"14 12","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11678502/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prognostic Assessment with the Malnutrition Universal Screening Tool in Heart Transplant Recipients: A Pilot Study and a Single-Center Experience.\",\"authors\":\"Assunta Fabozzo, Valentina Lombardi, Giorgia Cibin, Emma Bergonzoni, Giulia Lorenzoni, Dario Gregori, Chiara Tessari, Daniela Bacich, Augusto D'Onofrio, Giuseppe Toscano, Antonio Gambino, Vincenzo Tarzia, Nicola Pradegan, Gino Gerosa\",\"doi\":\"10.3390/jpm14121140\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction and aims</b>: Malnutrition is associated with increased morbidity and mortality in patients who undergo cardiac surgery. Nevertheless, objective assessment of malnourished patients undergoing heart transplantation (HT) is limited. We aimed to analyze the relationship between the malnutrition status and the early and late clinical outcomes of patients undergoing HT using a novel semi-quantitative tool. <b>Methods</b>: All patients aged ≥18 years who underwent HT between January 2015 and July 2020 in a single center were retrospectively evaluated and included in the study. The semi-quantitative Malnutrition Universal Screening Tool (MUST) score (already validated in heart failure) was calculated for each patient at the time of transplantation to assess their nutritional status. A propensity score weighting approach was performed to evaluate the association between the increase in MUST score and the risk of early complications and in-hospital mortality. A Cox regression analysis was performed to assess follow-up mortality. <b>Results</b>: A total of 168 HT patients (median age 58.4 years, IQR 49.5-65.2, men <i>n</i> = 128, 76%) were included within the study period. Their median preoperative BMI was 24.0 kg/m<sup>2</sup> (IQR 21.2-27.9). Preoperative MUST scores of 0, 1, and ≥2 were found in 92 (55%), 24 (14%), and 52 (31%) patients, respectively. The median preoperative eGFR was 64.3 mL/min (IQR 49.0-83.2). An increase in MUST score (from 0 to 2) was not significantly related to major postoperative complications or in-hospital mortality. An analogous increase in MUST score was associated with increased follow-up mortality risk (hazard ratio 1.28, 95% CI 1.04-1.83, <i>p</i> = 0.024). <b>Conclusions</b>: Malnutrition assessed with the MUST score seems not to be associated with increased in-hospital mortality or major postoperative complications in patients who undergo HT, but according to our preliminary data it is related to patients' long-term mortality.</p>\",\"PeriodicalId\":16722,\"journal\":{\"name\":\"Journal of Personalized Medicine\",\"volume\":\"14 12\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-12-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11678502/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Personalized Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jpm14121140\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm14121140","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
简介和目的:在接受心脏手术的患者中,营养不良与发病率和死亡率增加有关。然而,对接受心脏移植(HT)的营养不良患者的客观评估是有限的。我们的目的是利用一种新颖的半定量工具来分析营养不良状况与接受激素疗法患者早期和晚期临床结果之间的关系。方法:回顾性评估2015年1月至2020年7月在单一中心接受HT治疗的所有年龄≥18岁的患者并纳入研究。在移植时计算每个患者的半定量营养不良通用筛查工具(MUST)评分(已经在心力衰竭中得到验证),以评估他们的营养状况。采用倾向评分加权法评估MUST评分增加与早期并发症和住院死亡率风险之间的关系。采用Cox回归分析评估随访死亡率。结果:研究期间共纳入168例HT患者(中位年龄58.4岁,IQR为49.5 ~ 65.2,男性128例,76%)。术前中位BMI为24.0 kg/m2 (IQR 21.2-27.9)。术前MUST评分为0、1和≥2的患者分别为92例(55%)、24例(14%)和52例(31%)。术前中位eGFR为64.3 mL/min (IQR为49.0-83.2)。MUST评分的增加(从0到2)与主要术后并发症或住院死亡率无显著相关性。MUST评分的类似增加与随访死亡风险增加相关(风险比1.28,95% CI 1.04-1.83, p = 0.024)。结论:MUST评分评估的营养不良似乎与HT患者住院死亡率或主要术后并发症的增加无关,但根据我们的初步数据,它与患者的长期死亡率有关。
Prognostic Assessment with the Malnutrition Universal Screening Tool in Heart Transplant Recipients: A Pilot Study and a Single-Center Experience.
Introduction and aims: Malnutrition is associated with increased morbidity and mortality in patients who undergo cardiac surgery. Nevertheless, objective assessment of malnourished patients undergoing heart transplantation (HT) is limited. We aimed to analyze the relationship between the malnutrition status and the early and late clinical outcomes of patients undergoing HT using a novel semi-quantitative tool. Methods: All patients aged ≥18 years who underwent HT between January 2015 and July 2020 in a single center were retrospectively evaluated and included in the study. The semi-quantitative Malnutrition Universal Screening Tool (MUST) score (already validated in heart failure) was calculated for each patient at the time of transplantation to assess their nutritional status. A propensity score weighting approach was performed to evaluate the association between the increase in MUST score and the risk of early complications and in-hospital mortality. A Cox regression analysis was performed to assess follow-up mortality. Results: A total of 168 HT patients (median age 58.4 years, IQR 49.5-65.2, men n = 128, 76%) were included within the study period. Their median preoperative BMI was 24.0 kg/m2 (IQR 21.2-27.9). Preoperative MUST scores of 0, 1, and ≥2 were found in 92 (55%), 24 (14%), and 52 (31%) patients, respectively. The median preoperative eGFR was 64.3 mL/min (IQR 49.0-83.2). An increase in MUST score (from 0 to 2) was not significantly related to major postoperative complications or in-hospital mortality. An analogous increase in MUST score was associated with increased follow-up mortality risk (hazard ratio 1.28, 95% CI 1.04-1.83, p = 0.024). Conclusions: Malnutrition assessed with the MUST score seems not to be associated with increased in-hospital mortality or major postoperative complications in patients who undergo HT, but according to our preliminary data it is related to patients' long-term mortality.
期刊介绍:
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.